This is a routine administrative filing for an upcoming shareholder meeting. Traders should note that the vote on executive compensation is advisory and non-binding, and the shareholder proposal is likely to be defeated as it is against the board's recommendation. Monitor for any subsequent filings that may contain material financial information.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 16 $268.31entry
- T+1 · 8mo ago −1.89%α −2.16% · $263.24
- T+5 · 8mo ago −2.54%α −0.50% · $261.49
- T+20 · 7mo ago +1.34%α −2.44% · $271.91
- T+60 · 5mo ago +7.94%α −2.54% · $289.61
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
The Cigna Group has filed its definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, scheduled for April 22, 2026. The filing outlines the agenda, which includes the election of 12 directors, an advisory vote on executive compensation, ratification of the independent auditor, and a shareholder proposal on the right to act by written consent. The document was filed by the registrant (Cigna) and provides voting instructions for shareholders.
Key Facts
- The filing is a definitive proxy statement (DEFA14A) for The Cigna Group's 2026 Annual Meeting.
- The meeting is scheduled for April 22, 2026, and will be held virtually.
- The agenda includes the election of 12 directors, an advisory vote on executive compensation, ratification of PricewaterhouseCoopers LLP as the independent auditor, and a shareholder proposal on the right to act by written consent.
- The document was filed by the registrant, The Cigna Group.
Financial Impact
No direct financial impact is reported in this filing.
Risk Factors
- The advisory vote on executive compensation, while non-binding, could signal shareholder sentiment if it fails.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001140361-26-009400 |
| Document: 0001140361-26-009400-index-headers.html | 0001140361-26-009400 |
| Document: 0001140361-26-009400-index.html | 0001140361-26-009400 |
| Document: 0001140361-26-009400.txt | 0001140361-26-009400 |
Track record
16 reports on CI
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $301.48 to $296.27 Now $300.16 −0.44% ▼ −1.73% −5.02% vs SPY
- Oct 28, 202619d ago Press Release Neutral 2/10 Entry $298.41 to $301.48 Now $300.16 +0.59% ▲ +1.03% +5.75% vs SPY
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $295.00 to $305.41 Now $300.16 +1.75% ▲ +3.53% +4.24% vs SPY
- Oct 20, 202627d ago Institutional Cluster Neutral 3/10 Entry $304.37 to $298.28 Now $300.16 −1.38% ▼ −2.00% −1.56% vs SPY
- Oct 9, 20265w ago 8-K Neutral 2/10 Entry $283.34 to $298.50 Now $300.16 +5.94% ▲ +5.35% +6.84% vs SPY
- Sep 30, 20266w ago 8-K Neutral 4/10 Entry $271.83 to $278.51 Now $300.16 +10.42% ▲ +2.46% +0.54% vs SPY
- Sep 3, 202610w ago 144 Neutral 2/10 Entry $286.26 to $280.76 Now $300.16 +4.86% ▼ −1.92% −0.77% vs SPY
- Aug 18, 202612w ago 144 Neutral 2/10 Entry $278.50 to $279.32 Now $300.16 +7.78% ▲ +0.29% +0.50% vs SPY
- Aug 4, 202614w ago 144 Neutral 2/10 Entry $273.45 to $273.87 Now $300.16 +9.77% ▲ +0.16% +0.25% vs SPY
- Jul 9, 202618w ago 3 Neutral 2/10 Entry $293.46 to $283.82 Now $300.16 +2.28% ▼ −3.28% −2.72% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers